Rutaecarpine prevents hypoxia-reoxygenation-induced myocardial cell apoptosis via inhibition of NADPH oxidases

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 3, 2011, Pages 177-186

  Bao, Mei Hua ^a   Dai, Wen ^b   Li, Yuan Jian ^b   Hu, Chang Ping ^b  

^a CHANGSHA MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Hypoxia reoxygenation; Myocardial cell; Nadph oxidase; Rutaecarpine

Indexed keywords

LACTATE DEHYDROGENASE; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RUTAECARPINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL VIABILITY; ENZYME INHIBITION; FLOW CYTOMETRY; HEART MUSCLE CELL; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; UPREGULATION;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; CELL HYPOXIA; CELL SURVIVAL; ENZYME INHIBITORS; INDOLE ALKALOIDS; MYOCYTES, CARDIAC; NADPH OXIDASE; OXYGEN; QUINAZOLINES; RATS;

EID: 79952976830     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-006     Document Type: Article

References (44)

1. Ago, T., Kitazono, T., Ooboshi, H., Iyama, T., Han, Y.H., Takada, J., et al. 2004. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation, 109(2): 227-233. doi:10.1161/01.CIR.0000105680.92873.70. PMID:14718399.
2. Akki, A., Zhang, M., Murdoch, C., Brewer, A., and Shah, A.M. 2009. NADPH oxidase signaling and cardiac myocyte function. J. Mol. Cell. Cardiol. 47(1): 15-22. doi:10.1016/j.yjmcc.2009.04.004. PMID:19374908.
3. Al-Mehdi, A.B., Zhao, G., Dodia, C., Tozawa, K., Costa, K., Muzykantov, V., et al. 1998. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ. Res. 83(7): 730-737. PMID:9758643.
4. Becker, B.F., Kupatt, C., Massoudy, P., and Zahler, S. 2000. Reactive oxygen species and nitric oxide in myocardial ischemia and reperfusion. Z. Kardiol. 89(0 Suppl. 9): IX88-IX91. doi:10.1007/s003920070037. PMID:11151803.
5. Bedard, K., and Krause, K.H. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87(1): 245-313. doi:10.1152/physrev.00044.2005. PMID:17237347.
6. phox- containing NADPH oxidase inangiotensin II-induced cardiac hypertrophy in mice. Circulation, 105(3): 293-296. doi:10.1161/hc0302.103712. PMID:11804982.
7. Borchi, E., Parri, M., Papucci, L., Becatti, M., Nassi, N., Nassi, P., and Nediani, C. 2009. Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischaemia-reperfusion. J. Cell. Mol. Med. 13(8b): 2724-2735. doi:10.1111/j.1582-4934.2008.00485.x. PMID:18754815.
8. Brown, D.I., and Griendling, K.K. 2009. Nox proteins in signal transduction. Free Radic. Biol. Med. 47(9): 1239-1253. doi:10.1016/j.freeradbiomed.2009.07.023. PMID:19628035.
9. Byrne, J.A., Grieve, D.J., Bendall, J.K., Li, J.M., Gove, C., Lambeth, J.D., et al. 2003. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93(9): 802-805. doi:10.1161/01.RES.0000099504.30207.F5. PMID:14551238.
10. Cai, H., Griendling, K.K., and Harrison, D.G. 2003. The vascular NADPH oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24(9): 471-478. doi:10.1016/S0165-6147(03)00233-5. PMID:12967772.
11. Cave, A.C., Brewer, A.C., Narayanapanicker, A., Ray, R., Grieve, D.J., Walker, S., and Shah, A.M. 2006. NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal. 8(5-6): 691-728. doi:10.1089/ars.2006.8.691. PMID:16771662.
12. Chang, I.C., Huang, Y.J., Chiang, T.I., Yeh, C.W., and Hsu, L.S. 2010. Shikonin induces apoptosis through reactive oxygen species/extracellular signal-regulated kinase pathway in osteosarcoma cells. Biol. Pharm. Bull. 33(5): 816-824. doi:10.1248/bpb.33.816. PMID:20460760.
13. Chen, J.X., Zeng, H., Tuo, Q.H., Yu, H., Meyrick, B., and Aschner, J.L. 2007. NADPH oxidase modulates myocardial Akt, ERK1/2activation, and angiogenesis after hypoxia reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 292(4): H1664-H1674. doi:10.1152/ajpheart.01138.2006. PMID:17220182.
14. Choi, J.Y., Kim, B.M., Kim, Y.J., Woo, H.D., and Chung, H.W. 2007. Hypoxia/reoxygenation-induced cytotoxicity in cultured human lymphocytes. Biochem. Biophys. Res. Commun. 352(2): 366-371. doi:10.1016/j.bbrc.2006.11.036. PMID:17126811.
15. Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P.J., Ariyan, S., Dikalov, S., and Sorescu, D. 2005. NAD(P)H oxidase 4 mediates transforming growth factor-b1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97(9): 900-907. doi:10.1161/01.RES.0000187457.24338.3D. PMID:16179589.
16. Deng, P.Y., Ye, F., Cai, W.J., Tan, G.S., Hu, C.P., Deng, H.W., and Li, Y.J. 2004. Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine. J. Hypertens. 22(9): 1819-1829. doi:10.1097/00004872-200409000-00028. PMID:15311112.
17. Fukuda, K., Kojiro, M., and Chiu, J.F. 1993. Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis? Am. J. Pathol. 142(3): 935-946. PMID:8384410.
18. Fukui, T., Yoshiyama, M., Hanatani, A., Omura, T., Yoshikawa, J., and Abe, Y. 2001. Expression of p22phox and gp91phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochem. Biophys. Res. Commun. 281(5): 1200-1206. doi:10.1006/bbrc.2001.4493. PMID:11243862.
19. Gottlieb, R.A., Burleson, K.O., Kloner, R.A., Babior, B.M., and Engler, R.L. 1994. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94(4): 1621-1628. doi:10.1172/JCI117504. PMID:7929838.
20. Heo, S.K., Yun, H.J., Yi, H.S., Noh, E.K., and Park, S.D. 2009. Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation. J. Cell. Biochem. 107(1): 123-133. doi:10.1002/jcb.22109. PMID:19241441.
21. Honda, H.M., Korge, P., and Weiss, J.N. 2005. Mitochondria and ischemia/reperfusion injury. Ann. N. Y. Acad. Sci. 1047(1): 248-258. doi:10.1196/annals.1341.022. PMID:16093501.
22. Hu, C.P., Xiao, L., Deng, H.W., and Li, Y.J. 2002. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med. 68(8): 705-709. doi:10.1055/s-2002-33794. PMID:12221592.
23. Jacobson, G.M., Dourron, H.M., Liu, J., Carretero, O.A., Reddy, D.J., Andrzejewski, T., and Pagano, P.J. 2003. Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ. Res. 92(6): 637-643. doi:10.1161/01.RES.0000063423.94645.8A. PMID:12609967.
24. Jia, S., and Hu, C. 2010. Pharmacological effects of rutaecarpine as a cardiovascular protective agent. Molecules, 15(3): 1873-1881. doi:10.3390/molecules15031873. PMID:20336017.
25. Kajstura, J., Cheng, W., Reiss, K., Clark, W.A., Sonnenblick, E.H., Krajewski, S., et al. 1996. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74(1): 86-107. PMID:8569201.
26. Khaidakov, M., Szwedo, J., Mitra, S., Ayyadevara, S., Dobretsov, M., Lu, J., and Mehta, J.L. 2010. Anti-angiogenic and anti-mitotic effects of aspirin in hypoxia-reoxygenation modulation of LOX-1-NADPH oxidase axis as potential mechanism. J. Cardiovasc. Pharmacol. 56(6): 635-641. In press. doi:10.1097/FJC.0b013e3181f801e4. PMID:20881612.
27. Lambeth, J.D. 2004. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4(3): 181-189. doi:10.1038/nri1312. PMID:15039755.
28. Lefer, A.M., and Lefer, D.J. 1993. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu. Rev. Pharmacol. Toxicol. 33(1): 71-90. doi:10.1146/annurev.pa.33.040193.000443. PMID:8494355.
29. Li, J.M., and Shah, A.M. 2002. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277(22): 19952-19960. doi:10.1074/jbc.M110073200. PMID:11893732.
30. Li, J.M., Gall, N.P., Grieve, D.J., Chen, M., and Shah, A.M. 2002. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension, 40(4): 477-484. doi:10.1161/01.HYP.0000032031.30374.32. PMID:12364350.
31. Li, Q., Zhang, Y., Marden, J.J., Banfi, B., and Engelhardt, J.F. 2008. Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury. Biochem. J. 411(3): 531-541. doi:10.1042/BJ20071534. PMID:18397177.
32. Livak, K.J., and Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT. Methods, 25(4): 402-408. doi:10.1006/meth.2001.1262.PMID:11846609.
33. Matsuzawa, A., and Ichijo, H. 2005. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid. Redox Signal. 7(3-4): 472-481. doi:10.1089/ars.2005.7.472. PMID: 15706095.
34. Meischl, C., Krijnen, P.A., Sipkens, J.A., Cillessen, S.A., Muñoz, I.G., Okroj, M., et al. 2006. Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis. Apoptosis, 11(6): 913-921. doi:10.1007/s10495-006-6304-7.PMID:16544099.
35. Mu, Y.L., Xie, Y.Y., Zhou, L., Zhong, Y., Liu, L., Bai, H., et al. 2009. Cardioprotective effect of methylamine irisolidone, a new compound, in hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Chem. Biodivers. 6(8): 1170-1177. doi:10.1002/cbdv.200800314. PMID:19697334.
36. Ni, W., Zhan, Y., He, H., Maynard, E., Balschi, J.A., and Oettgen, P. 2007. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47phox gene expression in response to angiotensin II. Circ. Res. 101(10): 985-994. doi:10.1161/CIRCRESAHA.107.152439. PMID:17872466.
37. Qin, F., Patel, R., Yan, C., and Liu, W. 2006. NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin. Free Radic. Biol. Med. 40(2): 236-246. doi:10.1016/j.freeradbiomed.2005.08.010. PMID:16413406.
38. Qin, F., Simeone, M., and Patel, R. 2007. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction. Free Radic. Biol. Med. 43(2): 271-281. doi:10.1016/j.freeradbiomed.2007.04.021. PMID:17603936.
39. Ratych, R.E., and Bulkley, G.B. 1986. Free-radical-mediated post ischemic reperfusion injury in the kidney. J. Free Lett. Biol. Med. 2(5-6): 311-319. doi:10.1016/S0748-5514(86)80030-7.
40. Schumer, M., Colombel, M.C., Sawczuk, I.S., Gobé, G., Connor, J., O'Toole, K.M., et al. 1992. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am. J. Pathol. 140(4): 831-838. PMID:1562048.
41. Shin, H.K., Kim, Y.K., Kim, K.Y., Lee, J.H., and Hong, K.W. 2004. Remnant lipoprotein particles induced apoptosis in endothelial cells by NAD(P)H oxidase mediated production of superoxide and cytokines via lectin-like low density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation, 109(8): 1022-1028. doi:10.1161/01.CIR.0000117403.64398.53. PMID:14967724.
42. Spallarossa, P., Fabbi, P., Manca, V., Garibaldi, S., Ghigliotti, G., Barisione, C., et al. 2005. Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis. Biochem. Biophys. Res. Commun. 335(1): 188-196. doi:10.1016/j.bbrc.2005.07.064. PMID:16055083.
43. Tominaga, T., Kure, S., Narisawa, K., and Yoshimoto, T. 1993. Endonuclease activation following focal ischemic injury in the rat brain. Brain Res. 608(1): 21-26. doi:10.1016/0006-8993(93)90768-I. PMID:8388311.
44. Xiao, L., Pimentel, D.R., Wang, J., Singh, K., Colucci, W.S., and Sawyer, D.B. 2002. Role of reactive oxygen species and NAD(P)H oxidase in a1-adrenoceptor signaling in adult rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 282(4): C926-C934. PMID:11880281.